Molbio Diagnostics Limited
ListedMainboardHealthcare · NSE / BSE
Founded in 2000, Molbio Diagnostics Limited is a healthcare company focused on providing fast, accurate, and affordable diagnostic solutions for both infectious and non-communicable diseases. Its key product, the Truenat platform, is a portable PCR-based testing system that can deliver results within an hour, even in remote or low-resource areas, and is used to detect diseases like tuberculosis, COVID-19, hepatitis, HIV, and HPV. The company also offers radiology, digital pathology, and breast health screening solutions through its group entities and partners. It operates five manufacturing facilities across India to produce diagnostic devices, test kits, and portable X-ray systems. With a presence in over 80 countries and a strong distributor network, Molbio serves public health programs, hospitals, and diagnostic labs worldwide, generating revenue from both device sales and recurring test kit usage. As of March 31, 2025, the company had around 1,000 permanent employees along with over 1,500 contract workers.
Price Band
₹768 – ₹807
Issue Size
₹1164.62 L Cr
Lot Size
18 shares
GMP
₹116
+14.4%
Est. Listing
₹923
at current GMP
Subscribed
70.26x
overall
Open
10 Aug 2026
Close
12 Aug 2026
Allotment
13 Aug 2026
Refund
14 Aug 2026
Demat Credit
15 Aug 2026
Listing
17 Aug 2026
Last updated about 1 month ago
Official Registrar Verification
Molbio Diagnostics Limited Allotment Status
Designated Registrar: Kfin Technologies Limited
Allotment Date
13 Aug 2026
Basis finalization
Refunds Initiate
14 Aug 2026
Mandate release
Demat Credit
15 Aug 2026
Shares in demat
Listing Debut
17 Aug 2026
Trading begins
How to Check Molbio Diagnostics Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Kfin Technologies Limited's allotment portal.
- Select Molbio Diagnostics Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Molbio Diagnostics Limited Public Issue & Market Profile
Molbio Diagnostics Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,16,46,246 Crores. The shares are offered at a price band of ₹768 to ₹807 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2026-08-12, the basis of allotment is scheduled to be finalized on 2026-08-13. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.